Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer
暂无分享,去创建一个
A. Blackford | V. Stearns | J. Rae | K. Smith | J. Lehman | K. Kidwell | D. Hertz | C. Gersch | Y. Zong | A. Pesch | N. L. Henry